Impact des antalgiques opioïdes sur la sexualité des femmes suivies pour des douleurs chroniques non cancéreuses

ConclusionNotre étude a permis d’identifier le lien entre les antalgiques opioïdes et les DS féminines souvent mises sur le compte d’autres comorbidités comme les douleurs chroniques ou les troubles anxiodépressifs.SummaryIntroductionThe use of long-term opioid analgesics may contribute to the development of female sexual dysfunction (SD). We conducted a study to determine the impact of opioid analgesics on female sexuality.MethodsThis was a case-control study about 36 women aged between 18 and 40 years, who were treated with opioid analgesics for chronic non-cancer pain for at least 6 months. They were compared to 36 women who were not treated with opioid analgesics, matched by age and etiology of chronic pain. Data collection was based on medical records and using the following scales: Visual Analogue Scale (VAS), Hospital Anxiety and Depression Scale (HADS) and the Female Sexual Function index (FSFI).ResultsThe prevalence of SD in patients receiving opioid analgesics was 72.2% (P = 0.795). The average of the total FSFI score was smaller (18.96 ± 7.87) compared to the control group (22.24 ± 5.53), (P = 0.045). Statistical difference significance was found in mean scores for items: desire (P = 0.012), excitation (P = 0.013), and lubrication (P = 0.017), which were lower in patients treated with opioid analgesics. Menstrual disorder was associated with the use of opioid analgesics (P = ...
Source: Sexologies - Category: Sexual Medicine Source Type: research